IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Briapro Therapeutics C F

CUSIP: 107931107 | 3 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Ascentis Independent Advisors40
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Ascentis Independent Advisors
40$00.0%GrowthLowDallas, TX2026-11-03